---
layout: splash
title: 녹십자 (006280)
excerpt: 녹십자의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSPI
- P:의약품
keywords: 녹십자, 006280
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 159,400 | <span style="color: tomato">0.6<small>%</small></span> | P:의약품 | - | 1.4 | 0.9<small>%</small> |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | P:의약품 / 의약품 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 알부민외 제조, 판매 |
| <span style="white-space:nowrap;">**상장**</span> | KOSPI / 1989년 8월 1일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 허은철 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.gccorp.com](http://www.gccorp.com){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 10&#x2011;08 | | [임원ㆍ주요주주특정증권등소유상황보고서](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20241008000560){:target="_blank"} |
| 10&#x2011;07 | | [주식등의대량보유상황보고서(약식)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20241007000193){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![006280](/stock/images/006280.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 159,400 | <span style="color: tomato">0.6<small>%</small></span> | <span style="color: tomato">5.2<small>%</small></span> | <span style="color: tomato">3.7<small>%</small></span> | <span style="color: tomato">27.6<small>%</small></span> | <span style="color: tomato">42.2<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">47.6<small>%</small></span> | 36.9<small>%</small> | 1.29 | -15.8<small>%</small> | -6.7<small>%</small> | -3.0 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| P:의약품 | - | 1.4 | 0.9<small>%</small> | - |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/006280/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=006280){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A006280&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=006280){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/006280){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/006280/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![006280](/stock/images/006280_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 47.6<small>%</small> | 36.9<small>%</small> | 1.29 | -15.8<small>%</small> | -6.7<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 32.3<small>%</small> | 36.3<small>%</small> | 0.89 | -17.8<small>%</small> | -7.5<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | 26.5<small>%</small> | 25.2<small>%</small> | 1.05 | -17.4<small>%</small> | -3.8<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | 37.8<small>%</small> | 28.7<small>%</small> | 1.32 | -11.4<small>%</small> | -3.3<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | 39.3<small>%</small> | 29.2<small>%</small> | 1.35 | -13.9<small>%</small> | -4.0<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | 16.0<small>%</small> | 32.9<small>%</small> | 0.49 | -21.9<small>%</small> | -9.8<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | 20.6<small>%</small> | 33.1<small>%</small> | 0.62 | -19.4<small>%</small> | -8.4<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 21.8<small>%</small> | 32.0<small>%</small> | 0.68 | -16.5<small>%</small> | -6.9<small>%</small> |
| MACD[^fn_tech_metric_macd] | 62.2<small>%</small> | 29.4<small>%</small> | 2.12 | -11.4<small>%</small> | -2.8<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![006280](/stock/images/006280_corr.png){: .align-center}

|       | [삼성증권](/016360/) | [에이비엘바이오](/298380/) | [한전KPS](/051600/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [리가켐바이오](/141080/) | [GS건설](/006360/) | [대웅제약](/069620/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![006280](/stock/images/006280_2x.png){: .align-center}


> **관련 정보**

- [P:의약품 업종 목록](/stats/sector/kospi_업종_의약품_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}